[Cardiovascular risk in inflammatory bowel disease]

Presse Med. 2019 Dec;48(12):1365-1367. doi: 10.1016/j.lpm.2019.11.005.

[Article in French]

Author

Julien Kirchgesner¹

Affiliation

¹ AP-HP, hôpital Saint-Antoine, service de gastroentérologie et nutrition, 75571 Paris, France; Sorbonne université, Inserm, institut Pierre-Louis d'épidémiologie et de santé publique, 75646 Paris, France. Electronic address: julien.kirchgesner@aphp.fr.

PMID: 31822336
DOI: 10.1016/j.lpm.2019.11.005

No abstract available

Publication types

Editorial

MeSH terms

Adrenal Cortex Hormones / adverse effects
Cardiovascular Diseases* / etiology
Cardiovascular Diseases* / prevention & control
Crohn Disease / complications
Humans
Inflammation / complications
Inflammatory Bowel Diseases* / complications
Inflammatory Bowel Diseases* / drug therapy
Myocardial Ischemia / etiology
Proctocolitis / complications
Risk Assessment
Risk Factors
Smoking / adverse effects

Substances

Adrenal Cortex Hormones